Aptar Pharma continues its commitment to meeting new market trends with the release of an industry first, PureHale®, a new portable and ready-to-use delivery solution designed for upper respiratory care. PureHale® is a revolutionary and intuitive device which – when used in combination with saline or other natural ingredient formulations – may help relieve the symptoms of upper respiratory system conditions.
With the ongoing rise in pollution, which is a major environmental risk to health, the need for upper respiratory relief is more prominent than ever. Utilizing Aptar Pharma’s well-established Bag-on-Valve system, PureHale®’s innovative technology distributes a continuous fine mist (20-30µm) that gently cleanses, moisturizes and soothes the upper respiratory tract. When used in combination with a customer’s formulation, it may help to reduce irritations caused by coughs, colds, allergies, respiratory problems and dry nose/throat issues.
PureHale®’s portability allows consumers to apply wherever and whenever needed. Unlike traditional nebulizers, the PureHale® system does not require batteries or the prefilling of a reservoir and does not need to be plugged in or charged. The PureHale® technology platform is quiet and light, easy-to-use and includes mask and mouthpiece options, offering adaptable treatment and suitable for family use.
PureHale® will be officially launched at CPhI Worldwide in Madrid on October 9th at Booth 4D10 and is a finalist in the CPhI Pharma Awards in the Excellence in Pharma: Drug Delivery Device category.
